Clinical Trials

In this third installment of a 5-part series, the authors provide the tools for navigators to effectively guide patients through the clinical trial experience.

In this second installment of a 5-part series, the authors provide the tools for navigators to effectively guide patients through the clinical trial experience.

A clinical trial is recommended for your patient. Are you equipped to set them up for success?

Diverse representation is crucial to ensuring that clinical trial results are applicable to the entire population, not just select groups.

Amid low enrollment rates, this navigation initiative effectively provided patients and caregivers support in identifying appropriate clinical trials.

Navigators have 2 key roles related to the important work of improving diversity in clinical trials.

Cancer clinical trials offer patients an opportunity to be treated with the most cutting-edge and promising cancer therapies available, but the majority of patients who are offered these trials still are not signing up for them. This might frustrate those in the know, but many patients simply do not understand what these trials entail.

Executive Summary: Clinical trials for cancer treatments offer patients invaluable access to emerging therapies but are not always well understood by patients or even the medical community. Closing the gap between high patient interest levels and low patient enrollment will help thousands of patients benefit from cutting-edge therapies while accelerating advances for future patients.

Each year, approximately 250,000 cases of breast cancer are diagnosed in the United States.